Alvocidib inhibits <scp>IRF4</scp> expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth-Reference-Cited by-同舟云学术

Alvocidib inhibits IRF4 expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth

Published:2022-10-03 Issue:12 Volume:113 Page:4092-4103
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Sakamoto Hikaru¹²,Ando Koji³^ORCID,Imaizumi Yoshitaka³^ORCID,Mishima Hiroyuki⁴,Kinoshita Akira⁴,Kobayashi Yuji¹,Kitanosono Hideaki¹,Kato Takeharu²,Sawayama Yasushi²,Sato Shinya²,Hata Tomoko⁵,Nakashima Masahiro⁶,Yoshiura Koh‐Ichiro⁴⁷,Miyazaki Yasushi¹²³^ORCID

Affiliation:

1. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

2. Department of Hematology Nagasaki University Hospital Nagasaki Japan

3. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute Nagasaki University Nagasaki Japan

4. Department of Human Genetics, Atomic Bomb Disease Institute Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

5. Department of Clinical Laboratory Nagasaki Harbor Medical Center Nagasaki Japan

6. Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute Nagasaki University Nagasaki Japan

7. Division of Advanced Preventive Medical Sciences and Leading Medical Research Core Unit Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

Funder

Japan Society for the Promotion of Science

Chongqing University

National Natural Science Foundation of China

Chongqing Municipal Health Commission

Chongqing Science and Technology Commission

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15550